Cargando…

A Small Molecule Inhibitor of Signal Peptide Peptidase Inhibits Plasmodium Development in the Liver and Decreases Malaria Severity

The liver stage of Plasmodium's life cycle is the first, obligatory step in malaria infection. Decreasing the hepatic burden of Plasmodium infection decreases the severity of disease and constitutes a promising strategy for malaria prophylaxis. The efficacy of the gamma-secretase and signal pep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parvanova, Iana, Epiphanio, Sabrina, Fauq, Abdul, Golde, Todd E., Prudêncio, Miguel, Mota, Maria M.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659798/ https://www.ncbi.nlm.nih.gov/pubmed/19337374 http://dx.doi.org/10.1371/journal.pone.0005078

Ejemplares similares

Differential Inhibition of Signal Peptide Peptidase Family Members by Established γ-Secretase Inhibitors
por: Ran, Yong, et al.
Publicado: (2015)

Homeostasis Maintenance in Plasmodium-Infected Placentas: Is There a Role for Placental Autophagy During Malaria in Pregnancy?
por: Barateiro, André, et al.
Publicado: (2022)

Existing plaques and neuritic abnormalities in APP:PS1 mice are not affected by administration of the gamma-secretase inhibitor LY-411575
por: Garcia-Alloza, Monica, et al.
Publicado: (2009)

Maria M. Mota: Bringing Plasmodium Liver Infection to the Centre Stage of Malaria Research
por: Portugal, Sílvia, et al.
Publicado: (2022)

Signal peptide peptidase (SPP) dimer formation as assessed by fluorescence lifetime imaging microscopy (FLIM) in intact cells
por: Nyborg, Andrew C, et al.
Publicado: (2006)

IL-1α promotes liver inflammation and necrosis during blood-stage Plasmodium chabaudi malaria
por: de Menezes, Maria Nogueira, et al.
Publicado: (2019)

Genistein-Supplemented Diet Decreases Malaria Liver Infection in Mice and Constitutes a Potential Prophylactic Strategy
por: Cunha-Rodrigues, Margarida, et al.
Publicado: (2008)

Unlike the synchronous Plasmodium falciparum and P. chabaudi infection, the P. berghei and P. yoelii asynchronous infections are not affected by melatonin
por: Bagnaresi, Piero, et al.
Publicado: (2009)

Non-Canonical Notch Signaling Drives Activation and Differentiation of Peripheral CD4(+) T Cells
por: Dongre, Anushka, et al.
Publicado: (2014)

Transient pharmacologic lowering of Aβ production prior to deposition results in sustained reduction of amyloid plaque pathology
por: Das, Pritam, et al.
Publicado: (2012)

A Dedicated Promoter Drives Constitutive Expression of the Cell-Autonomous Immune Resistance GTPase, Irga6 (IIGP1) in Mouse Liver
por: Zeng, Jia, et al.
Publicado: (2009)

Plasmodium berghei-induced malaria decreases pain sensitivity in mice
por: Oyewole, Aboyeji L., et al.
Publicado: (2021)

Prevalence of a type-I interferon immune response against malaria liver stage infection
por: Liehl, Peter, et al.
Publicado: (2010)

Outbreak of Avian Malaria Associated to Multiple Species of Plasmodium in Magellanic Penguins Undergoing Rehabilitation in Southern Brazil
por: Vanstreels, Ralph Eric Thijl, et al.
Publicado: (2014)

Correction: Outbreak of Avian Malaria Associated to Multiple Species of Plasmodium in Magellanic Penguins Undergoing Rehabilitation in Southern Brazil
por: Vanstreels, Ralph Eric Thijl, et al.
Publicado: (2014)

C-Peptide Levels Predict the Effectiveness of Dipeptidyl Peptidase-4 Inhibitor Therapy
por: Demir, Sevin, et al.
Publicado: (2016)

Vigilin interacts with signal peptide peptidase
por: Lu, Stephen Hsueh-Jeng, et al.
Publicado: (2012)

Contribution of Murine Models to the Study of Malaria During Pregnancy
por: Barateiro, André, et al.
Publicado: (2019)

An Essential Signal Peptide Peptidase Identified in an RNAi Screen of Serine Peptidases of Trypanosoma brucei
por: Moss, Catherine X., et al.
Publicado: (2015)

Survey of Dipeptidyl Peptidase III Inhibitors: From Small Molecules of Microbial or Synthetic Origin to Aprotinin †
por: Abramić, Marija, et al.
Publicado: (2022)

Killer Bee Molecules: Antimicrobial Peptides as Effector Molecules to Target Sporogonic Stages of Plasmodium
por: Carter, Victoria, et al.
Publicado: (2013)

Plasmodium berghei-infection induces volume-regulated anion channel-like activity in human hepatoma cells
por: Prudêncio, Miguel, et al.
Publicado: (2009)

Docking simulation between HIV peptidase inhibitors and Trypanosoma cruzi aspartyl peptidase
por: Castilho, Vanessa V. S., et al.
Publicado: (2018)

New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
por: Cui, Chenkai, et al.
Publicado: (2022)

Inhibition of Plasmodium sporogonic stages by ivermectin and other avermectins
por: Azevedo, Raquel, et al.
Publicado: (2019)

Signal peptides and signal peptidase in Drosophila melanogaster
Publicado: (1980)

Peptidase Substrates via Global Peptide Profiling
por: Tagore, Debarati M., et al.
Publicado: (2008)

Angiotensin II Moderately Decreases Plasmodium Infection and Experimental Cerebral Malaria in Mice
por: Gallego-Delgado, Julio, et al.
Publicado: (2015)

Adverse pregnancy outcomes are associated with Plasmodium vivax malaria in a prospective cohort of women from the Brazilian Amazon
por: Dombrowski, Jamille Gregório, et al.
Publicado: (2021)

A Plasmodium berghei sporozoite-based vaccination platform against human malaria
por: Mendes, António M., et al.
Publicado: (2018)

Fonsecaea pedrosoi Sclerotic Cells: Secretion of Aspartic-Type Peptidase and Susceptibility to Peptidase Inhibitors
por: Palmeira, Vanila F., et al.
Publicado: (2018)

Adaptation of Helicoverpa armigera to Soybean Peptidase Inhibitors Is Associated with the Transgenerational Upregulation of Serine Peptidases
por: Velasquez-Vasconez, Pedro A., et al.
Publicado: (2022)

Expression of kallikrein-related peptidase 7 is decreased in prostate cancer
por: Zhang, Chong-Yu, et al.
Publicado: (2015)

In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules
por: Yan, Jingbo, et al.
Publicado: (2006)

Repurposing Drugs to Fight Hepatic Malaria Parasites
por: Fontinha, Diana, et al.
Publicado: (2020)

Further Possible Mechanisms of Dipeptidyl Peptidase-4 Inhibitors to Decrease Blood Glucose in Subjects with Type 2 Diabetes
por: Koshiyama, Hiroyuki
Publicado: (2011)

A genetically modified Plasmodium berghei parasite as a surrogate for whole-sporozoite vaccination against P. vivax malaria
por: Moita, Diana, et al.
Publicado: (2022)

Could Heme Oxygenase-1 Be a New Target for Therapeutic Intervention in Malaria-Associated Acute Lung Injury/Acute Respiratory Distress Syndrome?
por: Pereira, Marcelo L. M., et al.
Publicado: (2018)

Dipeptidyl peptidase IV inhibitors in diabetes: more than inhibition of glucagon-like peptide-1 metabolism?
por: Michel, Martin C., et al.
Publicado: (2008)

Repositioning of dipeptidyl peptidase-4 inhibitors and glucagon like peptide-1 agonists as potential neuroprotective agents
por: Mousa, Shaker A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ldd9iauj2uk4of2ka5f3rfqr4s